About Aragen Life Sciences
Aragen Life Sciences is a company based in Hyderabad (India) founded in 2001. It operates as a Professional Services, and Managed Services. Aragen Life Sciences has raised $195.65 million across 5 funding rounds from investors including Goldman Sachs, Avendus and Quadria Capital. The company has 3,859 employees as of April 08, 2024. Aragen Life Sciences has completed 3 acquisitions, including Aragen Bioscience, INTOX lab and Vanta Bioscience. Aragen Life Sciences offers products and services including Small Molecules and Large Molecules (Biologics). Aragen Life Sciences operates in a competitive market with competitors including Hybio Pharmaceutical, Nephron Pharmaceuticals, Suanfarma, Aiolos Bio and Kardigan, among others.
- Headquarter Hyderabad, India
- Employees 3859 as on 08 Apr, 2024
- Stage Minicorn
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Aragen Life Sciences Ltd.
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$195.64 M (USD)-4.42as on Mar 31, 2024
-
Net Profit
$18.7 M (USD)-27.18as on Mar 31, 2024
-
EBITDA
$50.54 M (USD)-13.01as on Mar 31, 2024
-
Total Equity Funding
$195.65 M (USD)
in 5 rounds
-
Latest Funding Round
$36 M (USD), Private Equity Round
Aug 13, 2025
-
Investors
Goldman Sachs
& 3 more
-
Employee Count
3859
as on Apr 08, 2024
-
Investments & Acquisitions
Aragen Bioscience
& 2 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aragen Life Sciences
Aragen Life Sciences offers a comprehensive portfolio of products and services, including Small Molecules and Large Molecules (Biologics). The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Small molecules are developed and manufactured for pharmaceuticals.
Biologics solutions are provided from gene to clinic.
Unlock access to complete
Unlock access to complete
Leadership Team
51 people
Senior Team
27 people
Software Development Team
24 people
Associate Team
20 people
Sales and Marketing
20 people
Scientific Team
19 people
Principal Team
18 people
Human Resources and Administration
13 people
Unlock access to complete
Funding Insights of Aragen Life Sciences
Aragen Life Sciences has successfully raised a total of $195.65M across 5 strategic funding rounds. The most recent funding activity was a Private Equity Round round of $36 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Private Equity Round — $36.0M
-
First Round
First Round
(08 Nov 2007)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2025 | Amount | Private Equity Round - Aragen Life Sciences | Valuation |
investors |
|
| Aug, 2025 | Amount | Series C - Aragen Life Sciences | Valuation | Avendus |
|
| Jan, 2025 | Amount | Private Equity Round - Aragen Life Sciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Aragen Life Sciences
Aragen Life Sciences has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Goldman Sachs, Avendus and Quadria Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Healthcare private equity investments focused on Asian markets.
|
Founded Year | Domain | Location | |
|
Investment banking services are delivered across multiple financial sectors.
|
Founded Year | Domain | Location | |
|
Sequoia Capital is engaged in venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Aragen Life Sciences
Aragen Life Sciences has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Aragen Bioscience, INTOX lab and Vanta Bioscience. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
GLP-certified preclinical contract research services are provided.
|
2010 | ||||
|
Preclinical contract research services in toxicology are offered.
|
1995 | ||||
|
CRO offering cell line development, protein and antibody production, in vivo models of human disease and safety studies.
|
1993 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Aragen Life Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Aragen Life Sciences Comparisons
Competitors of Aragen Life Sciences
Aragen Life Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Hybio Pharmaceutical, Nephron Pharmaceuticals, Suanfarma, Aiolos Bio and Kardigan, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Sterile pharmaceutical products are manufactured and contract services are provided.
|
|
| domain | founded_year | HQ Location |
Generics, nutraceuticals, and APIs are developed by Suanfarma.
|
|
| domain | founded_year | HQ Location |
Biotech company focused on developing innovative therapies for respiratory diseases and immune conditions
|
|
| domain | founded_year | HQ Location |
Biotech company developing personalized medicines for cardiovascular diseases
|
|
| domain | founded_year | HQ Location |
CDMO and analytical services for peptide development are provided.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Aragen Life Sciences
Frequently Asked Questions about Aragen Life Sciences
When was Aragen Life Sciences founded?
Aragen Life Sciences was founded in 2001 and raised its 1st funding round 6 years after it was founded.
Where is Aragen Life Sciences located?
Aragen Life Sciences is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Who is the current CEO of Aragen Life Sciences?
Manni Kantipudi is the current CEO of Aragen Life Sciences.
Is Aragen Life Sciences a funded company?
Aragen Life Sciences is a funded company, having raised a total of $195.65M across 5 funding rounds to date. The company's 1st funding round was a Private Equity Round of $100M, raised on Nov 08, 2007.
How many employees does Aragen Life Sciences have?
As of Apr 08, 2024, the latest employee count at Aragen Life Sciences is 3,859.
What is the annual revenue of Aragen Life Sciences?
Annual revenue of Aragen Life Sciences is $195.64M as on Mar 31, 2024.
What does Aragen Life Sciences do?
Aragen Life Sciences is involved in providing contract research, development, and manufacturing solutions for the pharmaceutical and biotech industries. Services are offered in small molecules and large molecules (biologics), covering discovery, development, and production. Operations are conducted across multiple global locations in Asia, North America, and Europe. Innovative solutions are delivered to support clients from concept to commercial stages. A focus is maintained on quality, sustainability, and intellectual property protection.
Who are the top competitors of Aragen Life Sciences?
Aragen Life Sciences's top competitors include Nephron Pharmaceuticals, Suanfarma and Hybio Pharmaceutical.
What products or services does Aragen Life Sciences offer?
Aragen Life Sciences offers Small Molecules and Large Molecules (Biologics).
How many acquisitions has Aragen Life Sciences made?
Aragen Life Sciences has made 3 acquisitions, including Aragen Bioscience, INTOX lab, and Vanta Bioscience.
Who are Aragen Life Sciences's investors?
Aragen Life Sciences has 4 investors. Key investors include Goldman Sachs, Avendus, Quadria Capital, and Sequoia Capital.
What is Aragen Life Sciences's valuation?
The valuation of Aragen Life Sciences is $272.82M as of Nov 2007.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.